102 related articles for article (PubMed ID: 12654184)
1. [Inhibition of triclosan to fatty acid synthase from goose uropygial glands and human breast cancer cells in vitro].
Wang YQ; Lai BS; Anderson VE
Ai Zheng; 2003 Mar; 22(3):270-3. PubMed ID: 12654184
[TBL] [Abstract][Full Text] [Related]
2. Triclosan inhibits enoyl-reductase of type I fatty acid synthase in vitro and is cytotoxic to MCF-7 and SKBr-3 breast cancer cells.
Liu B; Wang Y; Fillgrove KL; Anderson VE
Cancer Chemother Pharmacol; 2002 Mar; 49(3):187-93. PubMed ID: 11935210
[TBL] [Abstract][Full Text] [Related]
3. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.
Menendez JA; Ropero S; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Jun; 24(6):1369-83. PubMed ID: 15138577
[TBL] [Abstract][Full Text] [Related]
4. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
Menendez JA; Lupu R
Int J Mol Med; 2005 Jan; 15(1):33-40. PubMed ID: 15583825
[TBL] [Abstract][Full Text] [Related]
5. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
6. MRNA stability and overexpression of fatty acid synthase in human breast cancer cell lines.
Hunt DA; Lane HM; Zygmont ME; Dervan PA; Hennigar RA
Anticancer Res; 2007; 27(1A):27-34. PubMed ID: 17352212
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of fatty acid synthase-dependent neoplastic lipogenesis as the mechanism of gamma-linolenic acid-induced toxicity to tumor cells: an extension to Nwankwo's hypothesis.
Menendez JA; Colomer R; Lupu R
Med Hypotheses; 2005; 64(2):337-41. PubMed ID: 15607568
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of apoptosis induced by the inhibition of fatty acid synthase in breast cancer cells.
Bandyopadhyay S; Zhan R; Wang Y; Pai SK; Hirota S; Hosobe S; Takano Y; Saito K; Furuta E; Iiizumi M; Mohinta S; Watabe M; Chalfant C; Watabe K
Cancer Res; 2006 Jun; 66(11):5934-40. PubMed ID: 16740734
[TBL] [Abstract][Full Text] [Related]
9. A new targeting approach for breast cancer gene therapy using the human fatty acid synthase promoter.
Yan C; Wen-Chao L; Hong-Yan Q; Rui Z; Wei-Lin J; Hua H
Acta Oncol; 2007; 46(6):773-81. PubMed ID: 17653900
[TBL] [Abstract][Full Text] [Related]
10. Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts.
Pizer ES; Thupari J; Han WF; Pinn ML; Chrest FJ; Frehywot GL; Townsend CA; Kuhajda FP
Cancer Res; 2000 Jan; 60(2):213-8. PubMed ID: 10667561
[TBL] [Abstract][Full Text] [Related]
11. Fatty acid synthase is a potential molecular target for the chemoprevention of breast cancer.
Lu S; Archer MC
Carcinogenesis; 2005 Jan; 26(1):153-7. PubMed ID: 15358634
[TBL] [Abstract][Full Text] [Related]
12. Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells.
Zhou W; Simpson PJ; McFadden JM; Townsend CA; Medghalchi SM; Vadlamudi A; Pinn ML; Ronnett GV; Kuhajda FP
Cancer Res; 2003 Nov; 63(21):7330-7. PubMed ID: 14612531
[TBL] [Abstract][Full Text] [Related]
13. Theanaphthoquinone inhibits fatty acid synthase expression in EGF-stimulated human breast cancer cells via the regulation of EGFR/ErbB-2 signaling.
Weng MS; Ho CT; Ho YS; Lin JK
Toxicol Appl Pharmacol; 2007 Jan; 218(2):107-18. PubMed ID: 17182072
[TBL] [Abstract][Full Text] [Related]
14. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
15. Fatty acid synthase inhibition activates AMP-activated protein kinase in SKOV3 human ovarian cancer cells.
Zhou W; Han WF; Landree LE; Thupari JN; Pinn ML; Bililign T; Kim EK; Vadlamudi A; Medghalchi SM; El Meskini R; Ronnett GV; Townsend CA; Kuhajda FP
Cancer Res; 2007 Apr; 67(7):2964-71. PubMed ID: 17409402
[TBL] [Abstract][Full Text] [Related]
16. Hyperglycaemia confers resistance to chemotherapy on breast cancer cells: the role of fatty acid synthase.
Zeng L; Biernacka KM; Holly JM; Jarrett C; Morrison AA; Morgan A; Winters ZE; Foulstone EJ; Shield JP; Perks CM
Endocr Relat Cancer; 2010 Jun; 17(2):539-51. PubMed ID: 20356977
[TBL] [Abstract][Full Text] [Related]
17. Novel and potent inhibitors of fatty acid synthase derived from catechins and their inhibition on MCF-7 cells.
Zhang SY; Ma XF; Zheng CG; Wang Y; Cao XL; Tian WX
J Enzyme Inhib Med Chem; 2009 Jun; 24(3):623-31. PubMed ID: 18671164
[TBL] [Abstract][Full Text] [Related]
18. Increased fatty acid synthase expression and activity during progression of prostate cancer in the TRAMP model.
Pflug BR; Pecher SM; Brink AW; Nelson JB; Foster BA
Prostate; 2003 Nov; 57(3):245-54. PubMed ID: 14518031
[TBL] [Abstract][Full Text] [Related]
19. Fatty acid synthase inhibitors are chemopreventive for mammary cancer in neu-N transgenic mice.
Alli PM; Pinn ML; Jaffee EM; McFadden JM; Kuhajda FP
Oncogene; 2005 Jan; 24(1):39-46. PubMed ID: 15489885
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of fatty acid synthase for lung cancer treatment.
Orita H; Coulter J; Lemmon C; Tully E; Vadlamudi A; Medghalchi SM; Kuhajda FP; Gabrielson E
Clin Cancer Res; 2007 Dec; 13(23):7139-45. PubMed ID: 18056164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]